NCT04669795

Brief Summary

Deficient alveolar mandibular ridge corrected distraction osteogenesis to facilitate dental implant placement. Patients grouped into 2 groups: one group received Cissus quadrangularis during the consolidation period, and the other group received placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2019

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

2.1 years

First QC Date

December 2, 2020

Last Update Submit

December 9, 2020

Conditions

Keywords

AlveolarBoneDistraction

Outcome Measures

Primary Outcomes (4)

  • Bone gain after distraction

    Increase in bone height after distraction

    immediately at end of distractor activation

  • Relapse after distraction

    Relapse evaluated on panorama

    3 months from beginning of consolidation period

  • Crestal bone loss around dental implant

    By using cone beam CT, crestal bone level around implant evaluated by measuring a distance from implant apex to a point on dental implant where bone contacts the dental implant mesially and distally. then average of bone loss round each implant was obtained.

    6 months from implant placement

  • Bone density around dental implant

    By using cone beam CT, bone density assessed around dental implant at crestal, middle, and apical portions then average was obtained

    6 months from implant placement

Study Arms (2)

Group 1

PLACEBO COMPARATOR

Placebo was given to ten patients during consolidation period ( 2 capsule daily for 6 months during consolidation period)

Drug: Cissus Quadrangularis

Group 2

EXPERIMENTAL

Cissus quadrangularis in form of capsules given to ten patients ( 2 capsule daily for 6 months during consolidation period)

Drug: Cissus Quadrangularis

Interventions

Drug with osteogenic potential given to the patients after consolidation period. dose was two capsules once /day with meals for 6 weeks

Also known as: Hadiod capsule
Group 1Group 2

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients were included if they were free from any disease that may affect healing. Also, presented with 2-3 missing teeth at least in posterior area and CBCT showed bone height above inferior alveolar canal (IAC) ranged 8-10mm.

You may not qualify if:

  • patients were excluded if they suffered from any disease affect tissue healing, bad oral hygiene or heavy smoking patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dental medicine

Cairo, Nasr City, 11651, Egypt

Location

Related Publications (1)

  • Altaweel AA, Baiomy AABA, Shoshan HS, Abbas H, Abdel-Hafiz AA, Gaber AE, Zewail AA, Elshiekh MAM. Evaluation of osteogenic potential of Cissus quadrangularis on mandibular alveolar ridge distraction. BMC Oral Health. 2021 Oct 4;21(1):491. doi: 10.1186/s12903-021-01847-y.

MeSH Terms

Conditions

Diastasis, Bone

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and Injuries

Study Officials

  • Altaweel

    Al-Alharby university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

December 2, 2020

First Posted

December 17, 2020

Study Start

April 15, 2017

Primary Completion

May 30, 2019

Study Completion

August 15, 2019

Last Updated

December 17, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations